Research on the generation properties and pollution control of pharmaceutical manufacturing industry in China
-
摘要: 医药制造业是国家环境保护规划中重点治理的12个行业之一,其中约80%的污染是化学原料药生产过程中产生的。化学原料药产生的危险废物具有毒性、易燃性、腐蚀性、化学反应性、感染性、浸出毒性等危害特性,对生态环境具有极大的潜在危害。从发酵类、化学合成类以及提取类原料药的生产工艺流程出发,总结了各环节危险废物的产生及危害特性,分析了其利用和处置现状及存在的问题,针对性提出了原料药制造过程中典型危险废物利用和处置的对策建议:1)源头上减少环境风险;2)过程中提高企业清洁生产水平;3)末端利用中提升医药制造业危险废物资源化水平。Abstract: Pharmaceutical manufacturing industry is one of 12 key industries to be treated in the national environmental protection plan. About 80% of the pollution is caused by the production of chemical raw drugs. The hazardous wastes produced by chemical raw drugs possess the hazardous characteristics of toxicity, flammability, corrosiveness, chemical reactivity, infectivity and leaching toxicity, etc., which has great potential harm to the ecological environment. Starting from the process of fermentation pharmacy, chemical synthesis pharmacy and extraction pharmacy, the generation and hazard properties of hazardous wastes in each link were summarized, and the current situations and existing problems of their utilization and disposal were analyzed. The countermeasures and suggestions on the utilization and disposal of typical hazardous wastes were put forward as follows: 1) reducing environmental risks in the source, 2) improving the level of cleaner production in the process, 3) enhancing the resource level of hazardous waste in the end use of pharmaceutical manufacturing industry.
-
[1] 国务院. 关于印发《中国制造2025》的通知[A/OL].(2015-05-19)[2021-05-08]. http://www.gov.cn/zhengce/content/2015-05/19/content_9784.htm . [2] 何佳凝. 我国医药制造业污染分析及防治[J]. 中国国情国力, 2015(5):47-49. [3] 郝园. 医药化工行业VOCs及恶臭污染特性的研究[D]. 石家庄:河北科技大学, 2014. [4] 卫丽, 杜世勋, 卢中华, 等. 医药行业危险废物产生与污染特性初探[J]. 环境与可持续发展, 2015, 40(2):48-51.WEI L, DU S X, LU Z H, et al. Analysis for the generation and pollution characteristics of pharmaceutical hazardous wastes[J]. Environment and Sustainable Development, 2015, 40(2):48-51. [5] 生态环境部. 关于印发《重点行业挥发性有机物综合治理方案》的通知[A/OL].(2019-06-26)[2021-06-26]. http://www.mee.gov.cn/xxgk2018/xxgk/xxgk03/201907/t20190703_708395.html . [6] 环境保护部,国家发展和改革委员会,水利部. 关于印发《重点流域水污染防治规划(2016—2020年)》的通知[A/OL].(2020-10-19)[2017-10-19]. http://www.mee.gov.cn/gkml/hbb/bwj/201710/t20171027_424176.htm . [7] 国务院. 关于印发“十三五”生态环境保护规划的通知[A/OL].(2016-12-06)[2020-11-24]. http://www.mee.gov.cn/zcwj/gwywj/201811/t20181129_676583.shtml . [8] 工业和信息化部. 中国医药统计年报[M]. 北京: 中国统计出版社, 2016. [9] 工业和信息化部,生态环境部,国家卫生健康委, 等. 四部门关于印发《推动原料药产业绿色发展的指导意见》的通知[A/OL].(2020-01-02)[2021-04-10]. https://www.miit.gov.cn/zwgk/zcwj/wjfb/xfpgy/art/2020/art_b3c8238b6809444da60db7cd1e93c125.html . [10] 孙启宏, 韩明霞, 乔琦, 等. 辽河流域重点行业产污强度及节水减排清洁生产潜力[J]. 环境科学研究, 2010, 23(7):869-876.SUN Q H, HAN M X, QIAO Q, et al. Pollution generation intensity of key industries and water-saving and pollution reduction oriented and clean production potential in Liao River Basin[J]. Research of Environmental Sciences, 2010, 23(7):869-876. [11] 夏思佳, 赵秋月, 李冰, 等. 江苏省人为源挥发性有机物排放清单[J]. 环境科学研究, 2014, 27(2):120-126.XIA S J, ZHAO Q Y, LI B, et al. Anthropogenic source VOCs emission inventory of Jiangsu Province[J]. Research of Environmental Sciences, 2014, 27(2):120-126. [12] 国家发展和改革委员会. 关于印发化学原料药等6项行业清洁生产评价指标体系的通知[A/OL].(2020-12-31)[2021-04-10]. https://zfxxgk.ndrc.gov.cn/web/iteminfo.jsp?id=17693 . [13] 环境保护部. 发酵类制药工业水污染物排放标准:GB 21903—2008[S]. 北京: 中国环境科学出版社, 2008. [14] 李文. 医药废物的焚烧工艺选择与脱硫塔工艺设计[D]. 济南:山东大学, 2018. [15] 住房和城乡建设部. 医药工业废弃物处理设施工程技术规范:GB 51042—2014[S]. 北京: 中国计划出版社, 2015. [16] 环境保护部. 化学合成类制药工业水污染物排放标准:GB 21904—2008[S]. 北京: 中国环境科学出版社, 2008. [17] 环境保护部. 排污许可证申请与核发技术规范制药工业-原料药制造: HJ 858.1—2017[S]. 北京: 中国环境科学出版社, 2017. [18] 杜玉颖. 医药危废在工业窑炉中共处置的热化学反应和污染物排放特性的研究和应用[D]. 杭州:浙江大学, 2015. [19] 符凤英. 典型制药行业VOCs及恶臭污染控制技术评估体系研究[D]. 石家庄:河北科技大学, 2014. [20] 环境保护部. 提取类制药工业水污染物排放标准: GB 21905—2008[S]. 北京: 中国环境科学出版社, 2008. [21] CARLIER L, BARON M, CHAMAYOU A, et al. Greener pharmacy using solvent-free synjournal:investigation of the mechanism in the case of dibenzophenazine[J]. Powder Technology, 2013, 240:41-47.
doi: 10.1016/j.powtec.2012.07.009[22] de MILANESI M, RUNFOLA A, GUERCINI S. Pharmaceutical industry riding the wave of sustainability:review and opportunities for future research[J]. Journal of Cleaner Production, 2020, 261:121204.
doi: 10.1016/j.jclepro.2020.121204[23] GIOUMOUXOUZIS C I, KARAVASILI C, FATOUROS D G. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies[J]. Drug Discovery Today, 2019, 24(2):636-643.
doi: 10.1016/j.drudis.2018.11.019[24] WANG D P, CHEOW W S, AMALINA N, et al. Selecting optimal pharmaceutical excipient formulation from life cycle assessment perspectives:a case study on ibuprofen tablet formulations[J]. Journal of Cleaner Production, 2021, 292:126074.
doi: 10.1016/j.jclepro.2021.126074[25] JONES M, MAUTNER A, LUENCO S, et al. Engineered mycelium composite construction materials from fungal biorefineries:a critical review[J]. Materials & Design, 2020, 187:108397.
点击查看大图
计量
- 文章访问数: 635
- HTML全文浏览量: 125
- PDF下载量: 95
- 被引次数: 0